Further clinical data on the more rapid achievement of remission without the use of steroids with tocilizumab compared to methotrexate in giant-cell arteritis
Intern Emerg Med
.
2024 Nov 4.
doi: 10.1007/s11739-024-03769-3.
Online ahead of print.
Authors
Lukasz Szarpak
1
2
,
Basar Cander
3
,
Michal Pruc
4
5
Affiliations
1
Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, One Baylor Plaza, BCM285, Houston, TX, 77030, USA.
[email protected]
.
2
Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland.
[email protected]
.
3
Department of Emergency Medicine, Bezmialem Vakif University, Fatih, Istanbul, Turkey.
4
Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland.
5
Department of Public Health, International European University, Kiev, Ukraine.
PMID:
39495354
DOI:
10.1007/s11739-024-03769-3
No abstract available
Keywords:
Giant cell arteritis; Methotrexate; Steroid-free remission; Tocilizumab.